2019 annual financial data
Lyell Immunopharma 2019 Financial results
Direct answer
Revenue was 657,000 USD.
Operating income was -102.09M USD and net income was -129.38M USD.
Operating cash flow was 39.47M USD.
Get free Lyell Immunopharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 657,000 USD
- Operating income
- -102.09M USD
- Net income
- -129.38M USD
- Operating cash flow
- 39.47M USD
Explore related company data
View all 2019 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all Lyell Immunopharma financial years